~~<i id='B17F6E749F'><strike id='B17F6E749F'><tt id='B17F6E749F'><pre id='B17F6E749F'></pre></tt></strike></i>~~

Home» focus» comprehensive

comprehensive

author：focus 2025-10-06 09:43:13 Page View：426

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： PBM reforms clear House panel
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

Wikipedia

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Anthos stroke drug appears safer than common blood thinner

AdobePHILADELPHIA—Aninvestigationaldrugaimedatpreventingstrokessignificantlyreducedtheriskofbleeding

WSS

comprehensive

comprehensive

leisure time

Wikipedia

Anthos stroke drug appears safer than common blood thinner